Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma

E. Orlandi; M. Lazzarino; P. Bernasconi; C. Astori; C. Bernasconi

Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma

E. Orlandi, M. Lazzarino, P. Bernasconi, C. Astori, C. Bernasconi

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.

Original language	English
Pages (from-to)	758-759
Number of pages	2
Journal	Haematologica
Volume	83
Issue number	8
Publication status	Published - 1998

Keywords

Secondary leukemia
VP16

ASJC Scopus subject areas

Hematology

Cite this

@article{5218aa93cde54655bf48d3b604a8ef1c,

title = "Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma",

abstract = "We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.",

keywords = "Secondary leukemia, VP16",

author = "E. Orlandi and M. Lazzarino and P. Bernasconi and C. Astori and C. Bernasconi",

year = "1998",

language = "English",

volume = "83",

pages = "758--759",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "8",

}

TY - JOUR

T1 - Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma

AU - Orlandi, E.

AU - Lazzarino, M.

AU - Bernasconi, P.

AU - Astori, C.

AU - Bernasconi, C.

PY - 1998

Y1 - 1998

N2 - We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.

AB - We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.

KW - Secondary leukemia

KW - VP16

UR - http://www.scopus.com/inward/record.url?scp=0031722843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031722843&partnerID=8YFLogxK

M3 - Article

C2 - 9793267

AN - SCOPUS:0031722843

VL - 83

SP - 758

EP - 759

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 8

ER -

Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this